Proven choice for a better outcome
Supported by a wealth of clinical evidence, Accel‑Heal® is the ideal choice for patients suffering with poorly or non-healing ulcers because it works by addressing a key reason why wounds do not heal. It delivers a sequence of pre-programmed, low-level and painless electrical energy through the skin surface which helps to reduce the inflammation and improves cell migration to the ulcer site. This results in tissue repair turning a non-healing ulcer into one that heals normally.
Used alongside standard dressings without the need for a change in treatment plan, Accel‑Heal® improves treatment outcomes and the quality of life and wellbeing for patients by:
- Stimulating healing in hard to heal or non-healing leg ulcers
- Helping to reduce pain
- Reducing exudate
- Reducing oedema
It is a 12 day treatment course, consisting of six battery powered 48 hour single use units and connected electrode pads.
Evidence based, cost and clinically effective
The clinical efficacy of Accel‑Heal® has been established in a number of independent evaluations.
A recent study to assess the effectiveness of Accel‑Heal® demonstrated a significant reduction to the ulcer size, exudate levels and pain in 95% of the patients, with 77% achieving full closure. The treatment yielded an average of 34% reduction in the requirement for nurse visits and a 26% reduction in the number of dressings used. All patients with a wound duration of under 12 months acheived 100% wound healing.
Treating wounds with Accel‑Heal® at the optimal point in a care pathway would impact on long-term savings with at least a 35% annual saving to the NHS.
Information for Commissioners
- Product information
- Accel‑Heal® research
- Success stories
- Frequently asked questions
- Latest news